Iofina Regulatory News (IOF)

10 June 2014

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

Result of AGM & Appointment of Directors

The Board of Iofina is pleased to confirm that all resolutions put to shareholders at the Group's Annual General Meeting held today were duly passed.

The Board of Iofina is also pleased to announce the appointment of Tom Becker and Mike Coddington as Executive Directors of the Company.

Dr. Becker was the former vice president of Research and Development at H&S Chemical Company / Iofina Chemical ("H&S"). Iofina bought H&S in July 2009. Dr. Becker has conducted extensive research in both inorganic and organic halogen based chemistry. He has extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production and is the inventor on several chemical patents/patent applications. Prior to H&S, Dr. Becker worked as an Oak Ridge Scholar on behalf of the US EPA and for various other chemical manufacturing companies. Dr. Becker earned a BS in Chemistry from Indiana University, and a PhD in Chemistry from the University of Cincinnati.

Mr. Coddington has 30 years of Accounting and Finance experience in various manufacturing industries and previously served as the Group's Finance Director from 2010 until 2013. He was reappointed in 2014. Prior to joining the Company, he worked at Orflex Ltd, which was acquired by Diversapack LLC in 2001, at which he served as Corporate Finance Controller until 2010. Mr. Coddington holds a BBA in Finance and Accounting from the University of Cincinnati.

For further information, please contact:

Jeff Ploen, Interim CEO and President

Iofina

Tel: +44 (0)20 3006 3135

www.iofina.com

John Prior/Rupert Krefting/Paul Gillam

Numis Securities

Tel: +44 (0)20 7260 1000

Rob Collins

GMP Securities

Tel: +44(0)20 7647 2800

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, Montana and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

Director disclosures:

In relation to the appointment of Mr. Becker to the Board, Iofina confirms that there is nothing further to disclose in relation to his appointment under Schedule Two, paragraph (g) of the AIM Rules for Companies, save as disclosed below:

Full name: Thomas Matthew Becker

Age: 44

Current directorships/partnerships:

Iofina Chemical Inc

Previous directorships/partnerships in the last five years: None to disclose

Mr Becker holds no shares in the Company.

In relation to the appointment of Mr. Coddington to the Board, Iofina confirms that there is nothing further to disclose in relation to his appointment under Schedule Two, paragraph (g) of the AIM Rules for Companies, save as disclosed below:

Full name: Thomas Michael Coddington

Age: 58

Current directorships/partnerships:

Iofina Chemical Inc

Iofina Resources Inc

Previous directorships/partnerships in the last five years: None to disclose

Mr Coddington has a beneficial interest in 21,000 shares in the Company representing 0.02 per cent of its current issued share capital.